IVI launched the Valuing Innovation Project to bring together multiple stakeholder perspectives to consider how health technology assessment (HTA) can better account for innovations in health technology. As the first step, IVI hosted its third Annual Methods Summit (virtual event on October 6, 2022) to help frame the key issues different stakeholders are considering in measuring and rewarding innovation.
As the next step in this initiative, the Expert Roundtable is an invitation-only and in-person event that will convene a smaller group of experts across stakeholder groups to discuss specific topics related to methods and data preparedness highlighted during the Methods Summit. Topics for discussion include attributes used to define and measure innovation, process and methods to incorporate innovation considerations in HTA, and prioritized areas for future research and next steps.
The Expert Roundtable event will identify a shortlist of prioritized themes where additional research to better account for innovation in processes and methods to inform HTA is needed. The prioritized themes will inform a subsequent call for papers that will invite submissions that explore creative solutions to address data and method gaps in 2023.
Event Details
Date: Monday, October 17, 2022
Time: 12:00 PM – 4:00 PM EDT
Location: The Westin Alexandria Old Town (Alexandria, VA)
The event will be followed by IVI’s Annual Reception, from 4:30 PM – 6:30 PM EDT.
Agenda
12:00 PM – 12:30 PM || Lunch
12:30 PM – 1:30 PM || Session 1: Defining the Attributes of Innovation
1:30 PM – 2:30 PM || Session 2: Processes and Methods to Incorporation Innovation Considerations into HTA Processes
2:30 PM – 2:45 PM || Break
2:45 PM – 3:45 PM || Session 3: Next Steps
3:45 PM – 4:00PM || Wrap-Up
Speakers
Jon Campbell
Institute for Clinical and Economic Review
Jon Campbell, PhD
Jon is a leader in value assessment methods and application. As a member of ICER’s Senior Management Team, Jon directs ICER’s health economics impacts and leads the continued innovation of ICER’s value assessment methodology. Jon is a former faculty member of the University of Colorado and currently holds an affiliate faculty appointment at Tufts University School of Medicine.
Greg Baker
EmsanaRx
Greg Baker, RPh
As CEO, Greg Baker strategically develops EmsanaRx’s mission for drive better health, predictable costs and a partnership that puts employers in control. Greg has decades of experience in pharmacy as a pharmacist, businessman, and entrepreneur. He leads EmsanaRx in three core areas: 1. Cost Transparency, 2. Data Control and 3. Patient Health Improvement. He is passionate about creating a clinically-focused versus a financially-focused PBM.
At EmsanaRx, Greg leverages his prior experience working as the pharmacy lead for Premise Health, during which time he maintained the highest levels of operational efficiency, clinical excellence and customer service to provide value within the greater pharmacy healthcare ecosystem. Drawing from this experience, as well as time spent as Pharmacy Supervisor for Walgreens and Senior Pharmacy Consulting for Blue & Co., Greg listens to scores of employers across all industries to customize the highest quality clinical care solutions with the lowest costs for EmsanaRx customers. While in a previous role, Greg led a pharmacy organization that won the 2018 PBMI award for innovation and the 2019 APhA Pinnacle Award. He was also the first community pharmacist appointed by the HHS Secretary to the National Advisory Council for the Agency of Healthcare Research and Quality, where he further advanced the role of pharmacy to improve public health outcomes.
Greg Baker lives by the motto, “By employers, For employers,” in order to make EmsanaRx a nimble company in a large industry determined to do what is right for employers and the millions who work for them.
Mark Cziraky
HealthCore
Mark Cziraky, PharmD
As HealthCore’s co-founder and President, Mark Cziraky, PharmD, has been extensively involved with clinical, health economic and outcomes research for more than 25 years. Prior to becoming President, Mark was most responsible for leading Scientific Affairs and global scientific and business development at HealthCore. He has held additional leadership roles at HealthCore including running individual research units and leading business development teams. Mark remains dedicated to HealthCore’s mission to provide information to enable healthcare decision makers to asses the real-world value of pharmaceutical products and medical devices. He serves as a key architect in creating open-source research collaborations within the healthcare industry that allow health plans to be involved in research design and execution with various collaborating organizations.
Lou Garrison
University of Washington
Lou Garrison, PhD
Lou Garrison, PhD, is Professor Emeritus in The Comparative Health Outcomes, Policy, and Economics Institute in the School of Pharmacy at the University of Washington, where he joined the faculty in 2004. For the first 13 years of his career, he worked in non-profit health policy. Following this, he worked as an economist in the pharmaceutical industry for 12 years. He received a PhD in Economics from Stanford University, and has more than 190 publications in peer-reviewed journals. He was elected as ISPOR President for July 2016-June 2017, and currently serves as co-chair of ISPOR’s Policy Outlook Committee for the Health Science Policy Council. In September of this year, he was announced as the recipient of the 2022 Avedis Donabedian Outcomes Research Lifetime Achievement Award from ISPOR.
Jennifer Goldsack
Digital Medicine Society
Jennifer Goldsack, MChem, MA, MBA, OLY
Jennifer C. Goldsack founded and serves as the CEO of the Digital Medicine Society (DiMe), a 501(c)(3) non-profit organization dedicated to advancing digital medicine to optimize human health. Jennifer’s research focuses on applied approaches to the safe, effective, and equitable use of digital technologies to improve health, healthcare, and health research. She is a member of the Roundtable on Genomics and Precision Health at the National Academies of Science, Engineering and Medicine and serves on the World Economic Forum Global Leadership Council on mental health. Previously, Jennifer spent several years at the Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by Duke University and the FDA. There, she led development and implementation of several projects within CTTI’s Digital Program and was the operational co-lead on the first randomized clinical trial using FDA’s Sentinel System.
Jennifer spent five years working in research at the Hospital of the University of Pennsylvania, first in Outcomes Research in the Department of Surgery and later in the Department of Medicine. More recently, she helped launch the Value Institute, a pragmatic research and innovation center embedded in a large academic medical center in Delaware. Jennifer earned her master’s degree in chemistry from the University of Oxford, England, her masters in the history and sociology of medicine from the University of Pennsylvania, and her MBA from the George Washington University. Additionally, she is a certified Lean Six Sigma Green Belt and a Certified Professional in Healthcare Quality. Jennifer is a retired athlete, formerly a Pan American Games Champion, Olympian, and World Championship silver medalist.
Michael Graglia
SynGAP Research Fund
Michael Graglia, MBA, MA
Michael Graglia’s son Terry was diagnosed with SYNGAP1 in 2018, he was 4. Together with is wife, Ashley Evans, he founded the SynGAP Research Fund, 501(c)(3), to accelerate science around SYNGAP1 in order to make sure there is a therapy developed in a time frame that matters for his son, and children like him. SRF expects to have granted over $3.5M to scientific research by the end of 2022.
In the broader Rare Neuro community, Mike serves on the Executive Board of COMBINEDbrain and is a member of the AES Epilepsy Research Benchmarks Stewards Committee. Mike also represents SRF on the Personalized Medicine Coalition, Global Genes Foundation Alliance, EveryLife Foundation Community Congress, Rare Epilepsy Network, and Epilepsy Leadership Council.
Mike comes from a career in public policy, international development and strategy. Previous roles have included establishing a new program at New America, a DC think tank, Budget & Planning at both the Gates Foundation and Emerson Collective, healthcare consulting at BCG, supporting African Universities at the World Bank Group, managing a refugee program for the UNHCR via the ICMC in Zimbabwe, and teaching math in Peace Corps Namibia. Graglia has an MBA from Columbia where he was a Bronfman Fellow, an MA from Johns Hopkins School of Advanced International Studies where he was a Soros Fellow, and a BS in mathematics from Gonzaga University. Mike lives with his wife Ashley and two sons in Palo Alto, California.
Anna Hyde
Arthritis Foundation
Anna Hyde, MA
Anna Hyde is the Vice President of Advocacy and Access at the Arthritis Foundation. She oversees both the federal and state legislative programs, in addition to grassroots engagement. Her focus is to raise the visibility of arthritis as a public health priority, build support for federal and state legislation that ensure access to affordable, high-quality health care, and enhance patient engagement in the policy-making process. Anna previously served as Senior Director of Advocacy and Access, managing the federal affairs portfolio and overseeing the state advocacy team.
Prior to joining the Arthritis Foundation in 2014, Anna worked as Senior Manager for Federal Affairs at the American Congress of Obstetricians and Gynecologists, where she managed a portfolio of issues including appropriates, physician workforce, and health IT. She began her health policy career as a Congressional Fellow for Energy and Commerce Committee members, where she drafted legislation and staffed Committee activities. Anna received her BA in History from Southern Methodist University, and taught junior high and high school history before moving to Washington, D.C. in 2007 to pursue an MA in Political Science from American University.
Harry Kotlarz
Medical Device Innovation Consortium
Harry Kotlarz, MBA
Harry Kotlarz brings more than two decades of leading health economics and market access functions to his role as Program Director, Health Economics and Patient Value at the Medical Device Innovation Consortium (MDIC). He has a diverse background and experience representing start-up, established medical device companies including Medtronic and Johnson and Johnson as well as experience in Health Technology Assessment from his time at ECRI. His blend of industry experience, multiple stakeholder engagement, and evidence-based solutions has contributed to coverage and access for innovative technologies helping more patients. He has been responsible for the evidence required for value-based healthcare, reimbursement, and health policy-related issues including quality, new payment models, comparative effectiveness, and cost-effectiveness outcomes. He has collaborated closely with external stakeholders on how to deliver value and better patient outcomes in these new models of healthcare delivery. Harry obtained his MBA from Xavier University and BS from Thompson Rivers University.
Joshua Krieger
Harvard Business School
Joshua Kriger, PhD
Josh Krieger is an assistant professor of business administration in the Entrepreneurial Management Unit at Harvard Business School. Josh’s research focuses on R&D strategy and the economics of innovation. His work examines project portfolio investments, R&D competition, and how firms and research organizations adjust their R&D efforts in response to new information and resources. He taught the first year course, The Entrepreneurial Manager, and currently teaches a second year elective course: Tough Tech Ventures, which examines the development, commercialization and financing of cutting-edge science and technology.
Josh has a BA in economics and government at Cornell University. He received his PhD at the MIT Sloan School of Management. Prior to his doctoral studies, he worked in economic and litigation consulting at Cornerstone Research in Boston.
Maia Laing
Optum
Maia Laing, MBA
Maia is a seasoned healthcare professional with over 20 years of experience in healthcare care systems, policy, and quality improvement. She is a thought leader in improving access to quality care through human centered, data informed – innovation. Maia has demonstrated ability to drive outcomes across various healthcare sectors including non-profit healthcare delivery, government, and private industry. In the past, Maia worked for Brigham and Women’s Hospital, ranked top 20 hospital by U.S. News and World Report. She led innovation for the U.S. Department of Health and Human Service and most recently joined Optum.
Maia’s most celebrated accomplishments include leading the strategic roadmap for the Indian Health Service Health IT modernization and the development of Health+ a process that unleashes the power of data and technology to advance new solutions for underserved communities. She is passionate about improving the quality of life and treatment for people living with Sickle Cell disease.
Claire Sachs
The Patient Advocate’s Chronicle
Claire Sachs, MA
Claire Sachs, Founder of The Patient Advocate’s Chronicle and TPAC Consulting, spent most of her professional life avoiding anything healthcare because she had lived, breathed, and slept it 24 hours a day since 1983, when one near-fatal acute illness kicked off the development of what would become 14 chronic and recurring conditions. That changed in 2015 when she spoke for the first time about her patient experiences, and realized that all she had been through could be used to help people. Now she is combining that patient experience with the experience she has gained over two decades in Washington – primarily in policy and communications – to help her clients improve patient outcomes. In addition to sitting on IVI’s Patient Advisory Council, and Clair sits on patient advisory boards for the United States of Care, the ABIM Foundation, and the State of Maryland. She has also worked with the Society to Improve Diagnosis in Medicine and Families USA, and is an Ambassador for the Chronic Disease Coalition.